Telatinib

DRUG2 trials

Sponsors

Taizhou EOC Pharma Co., Ltd., Andrew Hendifar, MD

Conditions

Gastric CancerHepatocellular Carcinoma

Phase 2

Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer

Taizhou EOC Pharma Co., Ltd.Gastric Cancer

Start: 2019-01-25End: 2021-01-25Target: 90Updated: 2019-05-07

Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma

CompletedNCT04798781

Andrew Hendifar, MDGastric Cancer, Hepatocellular Carcinoma

Start: 2021-07-28End: 2025-10-20Updated: 2025-12-11